Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bitopertin

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Disc Medicine Reports Q3 2025 Financial Results & Business
    Disc Medicine Reports Q3 2025 Financial Results & Business

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182593/0/en/Disc-Medicine-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Disc Medicine Updates Hematology Portfolio And Business Goals
    Disc Medicine Updates Hematology Portfolio And Business Goals

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169201/0/en/Disc-Medicine-Provides-Update-on-Hematology-Portfolio-and-Outlines-Near-Term-Business-Objectives-and-Anticipated-Milestones.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Disc Medicine Receives FDA Priority Voucher For Bitopertin
    Disc Medicine Receives FDA Priority Voucher For Bitopertin

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3168389/0/en/Disc-Medicine-Announces-Receipt-of-FDA-Commissioner-s-National-Priority-Voucher-CNPV-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Disc Medicine Submits Bitopertin NDA For Accelerated EPP Approval
    Disc Medicine Submits Bitopertin NDA For Accelerated EPP Approval

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158587/0/en/Disc-Medicine-Announces-Submission-of-New-Drug-Application-NDA-to-US-FDA-for-Accelerated-Approval-of-Bitopertin-for-Patients-with-Erythropoietic-Protoporphyria-EPP.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Disc Medicine to Submit NDA for Bitopertin in EPP
    Disc Medicine to Submit NDA for Bitopertin in EPP

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118674/0/en/Disc-Medicine-Announces-Positive-Pre-NDA-Meeting-and-Confirms-Plans-to-Submit-NDA-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP-in-October-2025.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    Disc Host Call on Ph 2 FDA Meeting for Bitopertin in Protoporphyria
    Disc Host Call on Ph 2 FDA Meeting for Bitopertin in Protoporphyria

    01 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/01/2973535/0/en/Disc-Medicine-to-Host-Conference-Call-on-End-of-Phase-2-FDA-Meeting-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP.html

    GLOBENEWSWIRE
    01 Nov 2024
    Share Share